MicroTech Medical (Hangzhou) Co., Ltd
MicroTech Medical (Hangzhou) Co., Ltd., commonly referred to as MicroTech Medical, is a leading player in the medical device industry, headquartered in Hangzhou, China. Established in 2000, the company has made significant strides in developing innovative solutions for diabetes management, particularly through its advanced continuous glucose monitoring systems and insulin delivery devices. With a strong presence in both domestic and international markets, MicroTech Medical has positioned itself as a trusted provider of high-quality medical products. The company’s commitment to research and development has led to several key milestones, including the launch of its proprietary technology that enhances patient comfort and accuracy in glucose monitoring. Recognised for its excellence, MicroTech Medical continues to set benchmarks in the healthcare sector, making a substantial impact on the lives of patients worldwide.
DitchCarbon Score
How does MicroTech Medical (Hangzhou) Co., Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MicroTech Medical (Hangzhou) Co., Ltd's score of 19 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MicroTech Medical (Hangzhou) Co., Ltd's reported carbon emissions
MicroTech Medical (Hangzhou) Co., Ltd, headquartered in China, reported its carbon emissions for the years 2021 and 2022. In 2021, the company emitted approximately 1,106,370 kg CO2e, with 770 kg CO2e from Scope 1 emissions and about 1,106,200 kg CO2e from Scope 2 emissions. In 2022, emissions slightly increased to around 1,129,470 kg CO2e, comprising 820 kg CO2e from Scope 1 and approximately 1,129,380 kg CO2e from Scope 2. Despite these figures, MicroTech Medical has not disclosed any specific reduction targets or initiatives aimed at decreasing its carbon footprint. The absence of formal climate pledges or science-based targets indicates a potential area for improvement in their sustainability strategy. The company’s emissions per capita and per square metre metrics suggest ongoing operational impacts, with 1,140 kg CO2e per employee and 60 kg CO2e per square metre reported in 2022. As the industry increasingly prioritises climate commitments, MicroTech Medical's future strategies may benefit from establishing clear reduction goals to align with global sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 770 | 000 |
| Scope 2 | 1,106,200 | 0,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MicroTech Medical (Hangzhou) Co., Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
